| abstract |
An antimycobacterial combination comprising an effective amount of N- (3 - [[4- (3-trifluoromethylphenyl) piperazinyl] methyl] -2-methyl-5-phenyl-pyrrolyl) -4-pyridylcarboxamide of formula (I) or a salt non-toxic pharmaceutically acceptable thereof and a therapeutically effective amount of one or more first-line anti-tuberculosis drugs selected from the group consisting of isoniazid, rifampin, ethambutol, and pyrazinamide. |